A co-morbid patient of a phthisiologist, pulmonologist and cardiologist: focus on quality of life
https://doi.org/10.21292/2075-1230-2022-100-6-32-37
Abstract
The objective: to assess the impact of tuberculosis (TB), chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) on the quality of life (QOL) and the need to manage each disease to improve the physical and mental components of QOL.
Subjects and Methods. A simple prospective study included 80 patients, men – 53.9%, women – 46.1% who were divided into 3 groups: Group 1 – COPD (n = 35), median age [Me (25.0; 75.0 )] 56.0 (54.0; 60.0) years old, Group 2 – COPD + TB (n = 25), 58.0 (56.0; 59.0) years old, Group 3 – COPD + TB + CHF with preserved ejection fraction (n = 20), 60.0 (57.0; 64.0) years old. QOL was assessed using the SF-36 questionnaire. There were no statistically signifcant differences between the compared groups in terms of COPD severity and TB forms.
Results. Low QOL indices were observed in TB + COPD + CHF Group assessed by all scores especially for physical (30 points) and social functioning (35 points) and general health (35 points). After 3 months of therapy aimed to manage all pathological conditions, a positive trend in QOL was achieved in TB + COPD + CHF Group in terms of physical and mental health scores.
Conclusion. QOL in co-morbid patients is determined not only by the quality and severity of individual nosologies but also by their number. Comprehensive therapy improves the general subjective state of the patient that helps to improve adherence to drug therapy thereby increasing the chance of recovery.
About the Authors
M. V. Moiseeva
Omsk State Medical University
Russian Federation
Russian Federation
Marina V. Moiseeva, Candidate of Medical Sciences, Assistant of Polyclinic Therapy and Internal Diseases Department
12, Lenina St., Omsk, 644099
A. V. Mordyk
Omsk State Medical University; National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Anna V. Mordyk, Doctor of Medical Sciences, Professor, Head of Phthisiology, Phthisiosurgery and Infectious Diseases Department
12, Lenina St., Omsk, 644099
N. V. Bagisheva
Omsk State Medical University
Russian Federation
Russian Federation
Natalia V. Bagisheva, Candidate of Medical Sciences, Associate Professor of Polyclinic Therapy and Internal Diseases Department
12, Lenina St., Omsk, 644099
I. A. Viktorova
Omsk State Medical University
Russian Federation
Russian Federation
Inna A. Viktorova, Doctor of Medical Sciences, Associate Professor,
Head of Polyclinic Therapy and Internal Diseases Department
12, Lenina St., Omsk, 644099
S. A. Rudenko
Clinical TB Dispensary no. 4
Russian Federation
Russian Federation
Sergey A. Rudenko, Candidate of Medical Sciences, Head Physician.
Phone: +7 (3812) 95-68-20
8A, Khimikov St., Omsk, 644050
S. V. Sitnikova
Clinical TB Dispensary no. 4
Russian Federation
Russian Federation
Svetlana V. Sitnikova, Candidate of Medical Sciences, Phthisiologist, Deputy Chief Physician for Medical Activities.
Phone: +7 (3812) 95-68-29
8A, Khimikov St., Omsk, 644050
References
1. Amirdzhanova V.N., Goryachev D.V., Korshunov N.I., Rebrov A.P., Sorotskaya V.N. Sf-36 questionnaire population quality of life indices objective. Nauchno-Prakticheskaya Revmatologiya, 2008, no. 1, pp. 36-48. (In Russ.)
2. Bagisheva N.V., Moiseeva M.V., Viktorova I.A., Mordyk A.V., Mordyk D.I., Filipenko G.V. Quality of life for patients with chronic obstructive pulmonary disease, pulmonary tuberculosis and in the presence of the arterial hypertension. Meditsinsky Alyans, 2020, vol. 8, no. 3, pp. 37-45. (In Russ.) doi: 10.36422/23076348-2020-8-3-37-45.
3. Bagisheva N.V., Mordyk A.V., Viktorova I.A., Trukhan D.I. Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease. Meditsinsky Soviet, 2021, no. 14, pp. 142-148. (In Russ.) https://doi.org/10.21518/2079-701X-2021-14-142-148.
4. Zakharov E.V., Temnikova E.A. Quality of life of senile patients with chronic heart failure. Tyumenskiy Meditsinskiy Journal, 2014, vol. 16, no. 2, pp. 14-15. (In Russ.)
5. Lopatin Yu.M., Rosano Giuseppe M.K., Fragasso Gabriel, Lopashchuk Gari D., Seferovich Petar M., Goudac Louis Henrique V., Vinereanu Dragos, Hamid Magdi Abdel, Jourdain Patric, Ponikovsky Petr. Rationale for application, and benefits of trimetazidine in heart failure by its influence of myocardium metabolism. International Journal of Cardiology, 2016, no. 203, pp. 909-915. (In Russ.)
6. Novik A.A, Ionova T.I. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. [Guidelines on life quality assessment in medicine]. 2nd ed., Yu.L. Shevchenko, eds., Moscow, OLMAPRESS Publ., 2007, 313 p.
7. Temnikova E.A. Chronic heart failure in older people. Lechaschy Vrach, 2013, no. 10, pp. 81. (In Russ.)
8. Bui A.L., Horwich T.B., Fonarow G.C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol., 2011, no. 8, pp. 30-41.
9. ESC, Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur. Heart J., 2012, no. 33, pp. 1787-1847.
10. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation, 2010, no. 121, pp. 46-215.
Review
For citations:
Moiseeva M.V., Mordyk A.V., Bagisheva N.V., Viktorova I.A., Rudenko S.A., Sitnikova S.V. A co-morbid patient of a phthisiologist, pulmonologist and cardiologist: focus on quality of life. Tuberculosis and Lung Diseases. 2022;100(6):32-37. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-6-32-37
Views:
631
Email this article 